<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/9FEC614F-CEF7-46B0-8487-C9F9E5EC3DD9"><gtr:id>9FEC614F-CEF7-46B0-8487-C9F9E5EC3DD9</gtr:id><gtr:name>Quintiles Transnational Corporation</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/6EA29FCF-7F5D-4187-B33F-25000D54809E"><gtr:id>6EA29FCF-7F5D-4187-B33F-25000D54809E</gtr:id><gtr:name>Department of Health Social Services and Public Safety (DHSSPS)</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/D5337A10-AC8A-402A-8164-C5F9CC6B0140"><gtr:id>D5337A10-AC8A-402A-8164-C5F9CC6B0140</gtr:id><gtr:name>Queen Mary, University of London</gtr:name><gtr:address><gtr:line1>Mile End Road</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>E1 4NS</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D5337A10-AC8A-402A-8164-C5F9CC6B0140"><gtr:id>D5337A10-AC8A-402A-8164-C5F9CC6B0140</gtr:id><gtr:name>Queen Mary, University of London</gtr:name><gtr:address><gtr:line1>Mile End Road</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>E1 4NS</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/9FEC614F-CEF7-46B0-8487-C9F9E5EC3DD9"><gtr:id>9FEC614F-CEF7-46B0-8487-C9F9E5EC3DD9</gtr:id><gtr:name>Quintiles Transnational Corporation</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/6EA29FCF-7F5D-4187-B33F-25000D54809E"><gtr:id>6EA29FCF-7F5D-4187-B33F-25000D54809E</gtr:id><gtr:name>Department of Health Social Services and Public Safety (DHSSPS)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/2165B74E-9235-4B68-B481-EAB07E3083A9"><gtr:id>2165B74E-9235-4B68-B481-EAB07E3083A9</gtr:id><gtr:firstName>Mark</gtr:firstName><gtr:surname>Caulfield</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=MC_PC_14089"><gtr:id>C99886DC-CFBB-42EB-9420-B53F180E620F</gtr:id><gtr:title>UK Infrastructure for Large-scale Clinical Genomics Research</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Intramural</gtr:grantCategory><gtr:grantReference>MC_PC_14089</gtr:grantReference><gtr:abstractText>This proposal to the MRC will establish a shared, secure, high performance data and compute infrastructure as a platform for large-scale clinical genomics research based on the data flows of the UK 100,000 Genomes project.
Samples and data from patients with cancer and rare, inherited disorders will be provided by NHS England, working in collaboration with Cancer Research UK and programmes funded by the NIHR and the MRC. Genomics England, a company wholly owned by the Department of Health, will pay for the generation of whole genome sequence data.
Genomics England will pay also for the generation of summary reports, based upon clinical annotations of this data, and will return these to the NHS to support patient care. Genomics England will make anonymised, redacted versions of the data available for industrial research strictly within a secure, managed environment.
The proposed infrastructure will provide a similar environment for academic research, with a more comprehensive collection of genomic and patient data, including the read-level data used for the generation of variant calls and summary reports. The infrastructure will include software tools to support the production of 'research-ready' data sets, the effective management of patient and genomic data, and the delivery of collaborative clinical research.
The project partners have experience in infrastructure development and clinical genomics research, and will be able to reuse designs, procedures, and software developed and tested within existing programmes and organisations, including UK
Biobank and the European Bioinformatics Institute.
A formal mechanism will be established for engagement with public, charitable, and philanthropic funders, and with the clinical research projects that they fund. Subject to capacity constraints, projects that add appropriate value to the Genomics England programme will be provided with access to the compute infrastructure at no charge.</gtr:abstractText><gtr:technicalSummary>This proposal to the MRC will establish a shared, secure, high performance data and compute infrastructure as a platform for large-scale clinical genomics research based on the data flows of the UK 100,000 Genomes project.
Samples and data from patients with cancer and rare, inherited disorders will be provided by NHS England, working in collaboration with Cancer Research UK and programmes funded by the NIHR and the MRC. Genomics England, a company wholly owned by the Department of Health, will pay for the generation of whole genome sequence data. Genomics England will pay also for the generation of summary reports, based upon clinical annotations of this data, and will return these to the NHS to support patient care. Genomics England will make anonymised, redacted versions of the data available for industrial research strictly within a secure, managed environment. The proposed infrastructure will provide a similar environment for academic research, with a more comprehensive collection of genomic and patient data, including the read-level data used for the generation of variant calls and summary reports. The infrastructure will include software tools to support the production of 'research-ready' data sets, the effective management of patient and genomic data, and the delivery of collaborative clinical research. The project partners have experience in infrastructure development and clinical genomics research, and will be able to reuse designs, procedures, and software developed and tested within existing programmes and organisations, including UK Biobank and the European Bioinformatics Institute. A formal mechanism will be established for engagement with public, charitable, and philanthropic funders, and with the clinical research projects that they fund. Subject to capacity constraints, projects that add appropriate value to the Genomics England programme will be provided with access to the compute infrastructure at no charge.</gtr:technicalSummary><gtr:fund><gtr:end>2015-03-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2014-10-01</gtr:start><gtr:type>EXPENDITURE_ACTUAL</gtr:type><gtr:valuePounds>5997274</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Department of Health Social Services and Public Safety (DHSSPS)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Genomics England</gtr:description><gtr:id>82EF9E6A-92D4-495D-B28F-7360E26D9A65</gtr:id><gtr:impact>We have:
- returned diagnoses to the NHS
- created 13 NHS Genomic Medicine centres across England that serve to enrol, supply clinical data, validate feedback to patients
- embarked on the main programme 
- formed a 12 company consortium to create academic NHS Industry partnerships
- 9 HE Institutes now offer a Master's in Genomic Medicine</gtr:impact><gtr:outcomeId>YYCDjfdbSrn-1</gtr:outcomeId><gtr:partnerContribution>We are completing pilots in rare disease and cancer</gtr:partnerContribution><gtr:piContribution>I have been Chief Scientist for the 100000 whole genome sequencing programme since 2013.

I led and created the consortium that won the grant that creates this data centre for the research component of the 100,000 genomes project. This goes live for the main programme imminently (see further funding)</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Quintiles Transnational Corporation</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Quintiles Prime Site</gtr:description><gtr:id>5FED4B14-2782-4805-973F-722D4B0785B1</gtr:id><gtr:impact>It ranges across all therapeutic areas</gtr:impact><gtr:outcomeId>rEoKpxUXKB7-1</gtr:outcomeId><gtr:partnerContribution>Our collaboration with Quintiles, now extended across UCLP, created a world-leading trials hub bringing 168 new trials to 3356 UK patients (&amp;pound;
20m) and leading to creation of 25 similar &amp;quot;Prime Sites&amp;quot; worldwide.</gtr:partnerContribution><gtr:piContribution>I lead the World's first Prime Site which concentrates trials in a single site management organisation at Barts Health and Queen Mary University of London.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Genomics England - 100k Genome Project (Multiple National &amp; International Talks 2015-2017)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>6029DD07-0DAE-4385-BB9C-CDC99BC5EA00</gtr:id><gtr:impact>Multiple talks about the 100k Genomes project as GEL Chief Scientist</gtr:impact><gtr:outcomeId>58b9899ca41415.51457407</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:url>http://www.genomicsengland.co.uk</gtr:url><gtr:year>2015,2016,2017</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Chief Scientist for Genomics England - Progress Educational Trust</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>1F0FE6A2-97BE-4B07-A047-4595CE87A938</gtr:id><gtr:impact>Public meeting on the 100,00 Genomes Project, evoked discussions on the programme and data handling

Engagement from patient community</gtr:impact><gtr:outcomeId>5489bd8c24ffb8.47799903</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Chief Scientist for Genomics England Town Hall meetings</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>26FEE2EA-23EE-45A4-A4F1-F278242D1CB2</gtr:id><gtr:impact>Presented and co-led 3 of these meetings. Meetings sparked interesting and lively debates on the 100,000 genome project and what it means for patients

Project picked up by social media
Further events planned</gtr:impact><gtr:outcomeId>5489bccc7be417.92876918</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Chief Scientist Genomics England</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>4E89C024-C250-4C77-8B44-C8691BAE646A</gtr:id><gtr:outcomeId>CeKtZo8MxU9</gtr:outcomeId><gtr:type>Influenced training of practitioners or researchers</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Chief Scientist Genomics England</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>6204FF94-3A42-4063-83E5-E13EDA70A9E7</gtr:id><gtr:outcomeId>58b98e2fd95a22.65525515</gtr:outcomeId><gtr:type>Influenced training of practitioners or researchers</gtr:type><gtr:url>http://www.genomicsengland.co.uk</gtr:url></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Chief Scientist Genomics England</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>918C324D-617F-4614-985E-3D75DC9DD988</gtr:id><gtr:outcomeId>58b98e7fccdf44.09310438</gtr:outcomeId><gtr:type>Influenced training of practitioners or researchers</gtr:type><gtr:url>http://www.genomicsengland.co.uk</gtr:url></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Chief Scientist Genomics England</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>AE151E4C-246F-4D9C-9EF6-E6FCAD5192FF</gtr:id><gtr:outcomeId>58b98eaa94edf9.85681510</gtr:outcomeId><gtr:type>Influenced training of practitioners or researchers</gtr:type><gtr:url>http://www.genomicsengland.co.uk</gtr:url></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>Data Centre</gtr:description><gtr:id>D4E26B4F-80D4-4E37-A6FE-B28DF328BFA0</gtr:id><gtr:impact>The research data centre for analysis and interpretation of the 100,000 Genomes Project</gtr:impact><gtr:outcomeId>C92B480E24C</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>UK Clinical Genomics Research Infrastructure</gtr:title><gtr:type>Improvements to research infrastructure</gtr:type><gtr:yearFirstProvided>2014</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>I created and established the concept of NHS Genomic Medicine Centres in England which has led to NHS England Commissioning this capacity and capability framework for the 100,000 Genomes Project</gtr:description><gtr:id>372FF388-FCDC-413D-B150-BCBAFA79EC62</gtr:id><gtr:impact>Led to NHS England Commissioning this capacity and capability framework for the 100,000 Genomes Project</gtr:impact><gtr:outcomeId>548b1ee877cf84.23866217</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>NHS Genomic Medicine Centres</gtr:title><gtr:type>Improvements to research infrastructure</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>We have established, launched and called for expressions of interest to the UK NHS, academics and training to form domains to enhance clinical interpretation of the data from the 100,000 genomes project.</gtr:description><gtr:id>9AB1008F-612F-4230-9903-68FF770863C5</gtr:id><gtr:impact>Receiving expressions of interest for forming GeCIPs from research community</gtr:impact><gtr:outcomeId>548b1f43ed26b8.41054073</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>The Genomics England Clinical Interpretation Partnership</gtr:title><gtr:type>Improvements to research infrastructure</gtr:type><gtr:yearFirstProvided>2014</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>The sampling handling approaches and standard operating procedures for phenotyping been used to develop the automated Biobank sample handling system</gtr:description><gtr:id>2A90C2E1-FBCD-4CA5-9FE9-8E340C994F9F</gtr:id><gtr:impact>Handling 500000 samples now for UK Biobank</gtr:impact><gtr:outcomeId>10DC5461007</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Improved techniques</gtr:title><gtr:type>Improvements to research infrastructure</gtr:type><gtr:yearFirstProvided>2006</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Barts and The London Genome Centre. Offers high throughput genomics infrastructure to internal and external users including hotel facilities for scientists.</gtr:description><gtr:id>83027F4E-3FC9-4256-91C5-A8A735CDE77D</gtr:id><gtr:impact>Multiple major publications in common disease.</gtr:impact><gtr:outcomeId>0E3EC286575</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>High throughput genotyping and sequencing hub</gtr:title><gtr:type>Improvements to research infrastructure</gtr:type><gtr:yearFirstProvided>2008</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Taqman genotyping is a main workhorse for SNP genotyping. We adapted a methodology for reaction miniturisation from KBioscience for nanolitre reaction volumes reducing the cost of genotyping by 50%</gtr:description><gtr:id>043B7844-C036-4849-8D99-E4AB81DFB273</gtr:id><gtr:impact>added value for funders</gtr:impact><gtr:outcomeId>D0E9BE39BF9</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Genotyping technology</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:yearFirstProvided>2006</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Initially a microsoft access relational database which we migrated to MySQL database holding all phenotypic and genotypic data for analysis and ease of collaboration. Several other studies have copied or been helped to adapt our approach</gtr:description><gtr:id>ED65CAAB-DC84-4CF9-B4F1-0C0B9DD63B11</gtr:id><gtr:impact>Others have adopted the database structure for similar phenotypic collections</gtr:impact><gtr:outcomeId>178B48B4F89</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Phanotypic and genotypic database</gtr:title><gtr:type>Biological samples</gtr:type><gtr:yearFirstProvided>2007</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>9FC449C6-7FFB-4512-B47A-00E9F26F07AF</gtr:id><gtr:title>Biallelic Mutation of ARHGEF18, Involved in the Determination of Epithelial Apicobasal Polarity, Causes Adult-Onset Retinal Degeneration.</gtr:title><gtr:parentPublicationTitle>American journal of human genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/88f016512e3e841e2f352e85bc2a6c1d"><gtr:id>88f016512e3e841e2f352e85bc2a6c1d</gtr:id><gtr:otherNames>Arno G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0002-9297</gtr:issn><gtr:outcomeId>5a9d5205743d18.39143135</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0B21045A-7332-4D3D-A5D2-F8871D75BC17</gtr:id><gtr:title>Discovery of novel heart rate-associated loci using the Exome Chip.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/635664d7d143491072cf15526248ff34"><gtr:id>635664d7d143491072cf15526248ff34</gtr:id><gtr:otherNames>van den Berg ME</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>5a9d5205132934.26884516</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>67F05FC2-DC64-4A6C-8BC9-BF1435C14379</gtr:id><gtr:title>Clinical whole-genome sequencing from routine formalin-fixed, paraffin-embedded specimens: pilot study for the 100,000 Genomes Project.</gtr:title><gtr:parentPublicationTitle>Genetics in medicine : official journal of the American College of Medical Genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1b8888fe632202324e289dff1e8c0394"><gtr:id>1b8888fe632202324e289dff1e8c0394</gtr:id><gtr:otherNames>Robbe P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>1098-3600</gtr:issn><gtr:outcomeId>5a9d51ffd7d322.78368068</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0849E274-2022-459B-9892-DCE4FAE37E06</gtr:id><gtr:title>Exome-wide association study of plasma lipids in &amp;gt;300,000 individuals.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e5bd460d7c4191ca576be5ee64e1baf7"><gtr:id>e5bd460d7c4191ca576be5ee64e1baf7</gtr:id><gtr:otherNames>Liu DJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>5a9d520201ab72.80399165</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MC_PC_14089</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>F3822669-BB5A-4BB4-BAE0-DCB9DE36E092</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Generic Health Relevance</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1A41A859-2076-46E6-B80F-CE4E1E8EDC1D</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>1.5  Resources and infrastructure (underpinning)</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>93C4699B-9E5C-4982-9CCC-EFD5B9712D6E</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>2.6  Resources and infrastructure (aetiology)</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>